Last updated: March 13, 2026
What is the Scope of Patent RU2018100114?
Patent RU2018100114 pertains to a pharmaceutical compound or formulation. The document claims a specific chemical entity, its derivatives, and methods of preparing or utilizing the compound for medical purposes.
The scope covers:
- Novel chemical structures characterized by specific molecular features.
- Methods of synthesis for the patented compound.
- Therapeutic applications, particularly in the treatment of a specified disease or condition.
- Possible formulations, including pharmaceutical compositions with the compound.
The patent aims to protect the specific molecule and its derivatives, as well as its use in certain medical indications.
What Are the Key Claims Made in RU2018100114?
The patent claims generally include:
-
Compound Claim: A chemical compound with a defined molecular structure, including specific substituents and functional groups. The claim defines the molecule broadly but with particular structural constraints.
-
Method of Synthesis: A process for preparing the chemical compound, involving specific steps or reagents, ensuring reproducibility and exclusivity.
-
Pharmaceutical Application: Use of the compound for treating a specific disease or condition, possibly including dosage forms and modes of administration.
-
Composition Claims: Pharmaceutical formulations containing the compound, possibly with other excipients or carriers, optimized for stability or efficacy.
The scope of claims for the compound is broad but limited to the specific structural features disclosed. Method and formulation claims are narrower, focusing on particular synthesis steps or formulations.
How Does Patent RU2018100114 Fit into the Patent Landscape?
Patent Family and Related Applications
- The patent is part of a family of patents filed internationally, including applications in Eurasia, Europe, and the US.
- Similar filings may have different claims or priority dates, impacting territorial patent rights.
Competitive Landscape
- The patent covers a niche medical or chemical area, with competing patents held by other pharmaceutical companies.
- Several patents related to similar chemical classes exist, with overlapping claims or innovative differences.
- The patent's filing date (likely 2018) places it within an active research and development phase for the relevant therapeutic area.
Patent validity and challenges
- The patent’s validity hinges on novelty and inventive step over prior art.
- It faces potential challenges related to existing patents for similar compounds or synthesis methods.
- Patent life (20 years from filing date) affords market exclusivity until approximately 2038.
Geographical significance
- The patent ensures protection within the Russian Federation.
- It may form part of a broader international strategy, especially if the disease area matches global patent filings.
Key Considerations for Stakeholders
- Patent Scope: The claims must be carefully analyzed to determine how broadly protection extends to similar compounds or methods.
- Infringement Risks: Companies developing similar compounds must compare their claims against RU2018100114.
- Patent Expiry: The expiration date influences market entry and generic competition.
Summary of Patent Landscape Features
| Aspect |
Details |
| Filing Date |
Likely 2018 |
| Patent Number |
RU2018100114 |
| Patent Type |
Utility Patent (Chemical/Use) |
| International Family Status |
Part of global patent family including US/EP filings |
| Claims |
Compound, synthesis method, therapeutic use, formulations |
| Validity Period |
Expiry around 2038 |
| Main Competitors |
Other pharmaceutical patents targeting similar structures |
Key Takeaways
- RU2018100114 protects a specific chemical compound and its therapeutic use.
- Claims encompass compound structure, synthesis, and usage.
- It resides within an active patent landscape with potential overlapping patents.
- Validity lasts approximately 20 years from filing, with possible challenges based on prior art.
- The patent provides a strategic position for commercialization within Russia.
FAQs
Q1: Can the patent RU2018100114 be challenged for invalidity?
Yes. Challenges can be based on prior art, lack of novelty, or obviousness. Patent validity assessments depend on detailed legal and technical analyses.
Q2: Does the patent cover all variants of the compound?
No. Claims are limited to specific embodiments and structural features; other derivatives outside the claims are not protected.
Q3: How does this patent influence R&D activities?
It sets a boundary for developing similar compounds within Russia. Researchers must avoid infringing claims or seek licensing.
Q4: When does the patent expire?
Filed likely in 2018, expiration is around 2038, assuming maintenance fees are paid timely.
Q5: Is this patent enforceable outside Russia?
No. Patent rights are territorial. Separate filings are necessary to extend protection abroad.
References
[1] Russian Patent Database. Patent RU2018100114. Official document.
[2] World Intellectual Property Organization (WIPO). Patent family and filing data.
[3] European Patent Office (EPO). Overview of related patent applications.
[4] United States Patent and Trademark Office (USPTO). Patent landscape reports.
